Marinus Pharmaceuticals to Present at Upcoming Investor Conferences

Author's Avatar
May 03, 2023

Marinus+Pharmaceuticals%2C+Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that management will present and participate during the following conferences in May.